PF-06741086 Multiple Dose Study in Severe Hemophilia

NCT02974855 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer